Your browser is no longer supported. Please upgrade your browser to improve your experience.

Search Support Line

Need support now? It's free - call 0800 652 1102

Donate

Treatment

We're delighted to have been chosen as a finalist for the Respite and Carer Support Award.

Donanemab: NHS won’t fund new Alzheimer’s drug

Despite disappointment at Donanemab decision, NICE must consider funding to support dementia and carers.

Click to visit the Donanemab: NHS won’t fund new Alzheimer’s drug page Find out more

Lecanemab UK license for Alzheimer’s, not recommended by NICE

Lecanemab drug treatment for early Alzheimers is licensed for UK use; NICE must consider funding to support dementia and carers.

Click to visit the Lecanemab UK license for Alzheimer’s, not recommended by NICE page Find out more